Seroepidemiology of diphtheria and pertussis in Luxembourg in 2000

Epidemiology and Infection

Volumn 134, Issue 3, 2006, Pages 573-578

  Mossong, Joel ^a,b   Putz, L ^a,b   Shkedy, Z ^c   Schneider, F ^a  

^a LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

^b LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^c HASSELT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; TETANUS ANTIBODY;

ADOLESCENT; AGE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BORDETELLA PERTUSSIS; DIPHTHERIA; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFECTION PREVENTION; INFECTION RISK; LUXEMBOURG; MAJOR CLINICAL STUDY; NONHUMAN; PASSIVE IMMUNIZATION; PERTUSSIS; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEROLOGY;

EID: 33646124508     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268805005662     Document Type: Article

References (14)

1. Galazka A. The changing epidemiology of diphtheria in the vaccine era. Journal of Infectious Diseases 2000; 181 (Suppl 1): S2-S9.
2. Edmunds WJ, et al. The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiology and Infection 2000; 125: 113-125.
3. Levy-Bruhl D, et al. ESEN: A comparison of vaccination programmes. Part two: Pertussis. Eurosurveillance 1998; 3: 107-110.
4. Mossong J, Putz L, Schneider F. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg results from a national cross-sectional study. Epidemiology and Infection 2004; 132: 11-18.
5. Giammanco A, et al. European Sero-Epidemiology Network: Standardisation of the assay results for pertussis. Vaccine 2003; 22: 112-120.
6. Miyamura K, et al. Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration. Journal of Biological Standardization 1974; 2: 189-201.
7. Bowman AW, Azzalini A. Applied Smoothing Techniques for Data Analysis. Oxford: Clarendon Press, 1997.
8. Gay NJ, et al. Improving sensitivity of oral fluid testing in IgG prevalence studies: Application of mixture models to a rubella antibody survey. Epidemiology and Infection 2003; 130: 285-291.
9. Enquête de la couverture vaccinale au Grand-Duché de Luxembourg. Septembre-Octobre 1996. Direction de la Santé. Ministere de la Santé. Luxembourg, 1997.
10. Fine PEM. Adult pertussis: A salesman's dream - and an epidemiologist's nightmare. Biologicals 1997; 25: 195-198.
11. Horby P, et al. A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods. Epidemiology and Infection 2005; 133: 229-235.
12. Nardone A, Miller E, on behalf of the ESEN 2 Group. Serological surveillance of rubella in Europe. European Sero-Epidemiology Network (ESEN2). Eurosurveillance 2004; 9: 5-7.
13. Pebody RG, et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiology and Infection 2005; 133: 159-171.
14. Therre H, Baron S. Pertussis immunisation in Europe - the situation in late 1999. Eurosurveillance 2000; 5: 6-10.